IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Endo Acquires Patent for Oxymorphone Hydrochloride from Johnson Matthey

5:30 AM MDT | March 23, 2012 | Deepti Ramesh

Endo Pharmaceuticals (Chadds Ford, PA) says it has acquired U.S. patent for oxymorphone hydrochloride, the key active pharmaceutical ingredient (API) in all formulations of paint management product Opana, from Johnson Matthey (London). By acquiring Johnson Matthey's patent to the oxymorphone ingredient, which will be listed in the U.S. Food and Drug Administration's (FDA) orange book, Endo will enjoy additional patent protection for its Opana franchise, now through 2029, Endo says. “This patent not only covers our newly designed to be crush resistant Opana...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa